Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Journal of Human Immunity

Severe dengue: Are type I interferon autoantibodies involved?

13 affiliations
  1. 1Laboratory of Human Genetics of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA
  2. 2Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA
  3. 3Neonatal and Pediatric Intensive Care Unit, Mother, Child and Adolescent Department, Geneva University Hospitals, Geneva, Switzerland
  4. 4Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland
  5. 5Host-Pathogen Interaction Unit, San Matteo Research Hospital (Fondazione IRCCS Policlinico San Matteo), Pavia, Italy
  6. 6Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
  7. 7Laboratory of Human Genetics of Infectious Diseases, Université Paris Cité, Institut Imagine, Necker Branch, INSERM UMR 1163, Paris, France
  8. 8Department of Pediatrics, University of Texas Southwestern, Dallas, TX, USA
  9. 9Department of Immunology, University of Texas Southwestern, Dallas, TX, USA
  10. 10Children’s Hospital Research Institute, Dallas, TX, USA
  11. 11Howard Hughes Medical Institute, New York, NY, USA
  12. 12Department of Neurology, University of Texas Southwestern, Dallas, TX, USA
  13. 13Department of Neuroscience, University of Texas Southwestern, Dallas, TX, USA

Abstract

Dengue virus (DENV) is the most rapidly disseminating arbovirus worldwide. A new study by Yang et al. (https://doi.org/10.70962/jhi.20260072) shows that autoantibodies neutralizing type I IFNs (AAN-I-IFN) may underlie severe dengue in ∼14% (7/49) of cases in a cohort of Chinese patients. Further studies of children and adults of different ancestries with silent, benign, and severe DENV infection are warranted.

Related

  1. Sustained type I interferon activity and N-antigenemia form a vicious cycle during severe COVID-19.
    William Mouton, Kahina Saker, Priscille Franc +464
    EBioMedicinePeer-reviewedCC BY-NCFull textGeneral biologyEpidemiology & public healthEurope PMCCrossrefHAL
  2. T-cell-mediated immunodeficiency caused by anti-interferon-γ autoantibodies promotes the pathogenesis of Talaromycosis marneffei
    Jinglu Yang, Zhengtu Li, Xiao-Yun Yang +8
    PLOS Neglected Tropical DiseasesPeer-reviewedCC BY 4.0Full textCell biologyImmunologyPLOS
  3. Autoantibodies Against Type I Interferons and Death from H7N7 Avian Flu
    Qian Zhang, Ron A. M. Fouchier, Marcela Moncada-Velez +10
    The New England journal of medicinePeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  4. Narrative Review of the Bacterial Profile Involved in Severe COPD Exacerbations Complicated by Pneumonia in Patients Admitted to the Intensive Care Unit.
    Daniel Alexandru Jipa, Tamara Mirela Porosnicu, Patricia Hogea +6
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Factor VIII inhibitors demonstrate type I or type II kinetics in high‐titre alloantibodies and autoantibodies
    Cuicui Qiao, Jie Wang, Tiantian Wang +8
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
BibTeX
@article{tran2026severe,
  title = {{Severe dengue: Are type I interferon autoantibodies involved?}},
  author = {Vu Le-Huy Tran and Alessandro Borghesi and Jean-Laurent Casanova and Shen-Ying Zhang},
  journal = {Journal of Human Immunity},
  year = {2026},
  month = nov,
  doi = {10.70962/jhi.20260214},
  url = {https://doi.org/10.70962/jhi.20260214},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Severe dengue: Are type I interferon autoantibodies involved?
AU  - Vu Le-Huy Tran
AU  - Alessandro Borghesi
AU  - Jean-Laurent Casanova
AU  - Shen-Ying Zhang
PY  - 2026
DA  - 2026/11/12
JO  - Journal of Human Immunity
DO  - 10.70962/jhi.20260214
UR  - https://doi.org/10.70962/jhi.20260214
AB  - Dengue virus (DENV) is the most rapidly disseminating arbovirus worldwide. A new study by Yang et al. (https://doi.org/10.70962/jhi.20260072) shows that autoantibodies neutralizing type I IFNs (AAN-I-IFN) may underlie severe dengue in ∼14% (7/49) of cases in a cohort of Chinese patients. Further studies of children and adults of different ancestries with silent, benign, and severe DENV infection are warranted.
SN  - 3065-8993
ER  -